4 Retinitis Pigmentosa Clinical Trials in Tucson, AZ (2026)

Q: How do I join a clinical trial in Tucson?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you.

Recruiting Retinitis Pigmentosa Studies in Tucson

NCT06136650Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

The purpose of this study is to assess the efficacy and safety of opevesostat plus hormone replacement therapy (HRT) compared to alternative abiraterone acetate or enzalutamide in participants with Me...

Tucson, AZ1,314 participantsMerck Sharp & Dohme LLC

View Study Details

NCT03460977Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

The purpose of this study is to learn about the safety and effects of the study medicine (called Mevrometostat) for the possible treatment of Relapsed/ Refractory Small Cell Lung Cancer (SCLC), Castra...

Tucson, AZ453 participantsPfizer

View Study Details

NCT04757116Recruiting

Post-Market Study to Assess iTind Safety in Comparison to UroLift

The study objective is to evaluate the safety of the iTind device comparied to UroLift....

Tucson, AZ206 participantsOlympus Corporation of the Americas

View Study Details

NCT06208709Recruiting

Carpal Arch Space Augmentation (CASA) Clinical Trial

This research proposes to evaluate the effectiveness of a novel device designed for the treatment of carpal tunnel syndrome. The device applies a small cyclic force to the wrist. The cycles include a ...

Tucson, AZ116 participantsUniversity of Arizona

View Study Details

About Retinitis Pigmentosa Clinical Trials in Tucson

Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.

There are currently 4 retinitis pigmentosa clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 2,089 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Pfizer, Olympus Corporation of the Americas and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Retinitis Pigmentosa Clinical Trials in Tucson — FAQ

Are there retinitis pigmentosa clinical trials in Tucson?

Yes, there are 4 retinitis pigmentosa clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What retinitis pigmentosa treatments are being tested?

The 4 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.

Data updated July 13, 2026 from ClinicalTrials.gov